-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

102.O1.6 102. Iron Homeostasis and Biology I

Symposia: Iron Homeostasis and Biology Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, clinical trials, Iron Deficiency, adult, Biological therapies, Iron Overload, Non-Biological therapies, Translational Research, Clinical Research, Genetic Disorders, Thalassemia, embryo/fetus, Hemoglobinopathies, hematopoiesis, Other Pathogens, Diseases, real-world evidence, Therapies, pregnant, Infectious Diseases, metabolism, Biological Processes, Metabolic Disorders, molecular biology, Study Population, Human, pathogenesis, Animal model, Maternal Health
Monday, December 12, 2022: 4:30 PM-6:00 PM
388-390 (Ernest N. Morial Convention Center)
Moderators:
Maureen Okam Okam Achebe, MD, MPH, Hematology Division Brigham and Women's and Nermi Parrow, PhD, Saint Louis University School of Medicine
Disclosures:
Parrow: Protagonist: Consultancy.
4:30 PM

Sant-Rayn Pasricha, MD, PhD1,2,3,4, Martin Mwangi, PhD5*, Ernest Moya, BScN, MPH6*, Ricardo Ataide, PhD7,8*, Glory Mzembe, MBBS MSc5*, Rebecca Harding, BSc PhD9*, Truwah Zinenani, BSc6*, Danielle Clucas2,10*, Sabine Braat, MSc11,12* and Kamija S Phiri, MBBS DLSHTM MSc PhD5*

1Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Fitzroy North, VIC, Australia
2Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia
3Diagnostic Haematology, Royal Melbourne Hospital, Parkville, VIC, Australia
4Clinical Haematology, Royal Melbourne Hospital & Peter MacCallum Cancer Centre, Parkville, Australia
5Kamuzu University of Health Sciences (KUHeS), Training & Research Unit of Excellence (TRUE), Blantyre, Malawi
6Kamuzu University of Health Sciences (KUHeS), Training and Research Unit of Excellence, Blantyre, Malawi
7Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
8Department of Infectious Diseases, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
9Walter and Eliza Hall Institute of Medical Research, Population Health and Immunity Division, Parkville, Australia
10Diagnostic Haematology, The Royal Melbourne Hospital, Parkville, VIC, Australia
11Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
12Methods and Implementation Support for Clinical and Health Research Hub, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Parkville, Australia

4:45 PM

Sheridan L Helman, BSc1*, David M Frazer2*, Greg J. Anderson, BSc, MSc, PhD3* and Sarah J Wilkins, BSci3*

1QIMR Berghofer Medical Research Institute, Brisbane, Australia
2QIMR Berghofer Medical Research Institute, Herston, QLD, Australia
3QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia

5:00 PM

Simona Maria Di Modica, MSc1*, Claudia Benelli, BSc1,2*, Alessia Pagani, PhD1*, Emanuele Tanzi, MSc1*, Violante Olivari, MSc1,2*, Laura Silvestri, PhD1,2 and Antonella Nai, PhD1,2

1Division of Genetics and Cell Biology, IRCCS Ospedale San Raffaele, Milan, Italy
2Vita-Salute San Raffaele University, Milan, Italy

5:15 PM

Daniel Srole, Elizabeta Nemeth, PhD and Tomas Ganz, MD, PhD

Center for Iron Disorders, UCLA, Los Angeles, CA

5:30 PM

Rebecca Karp Leaf, MD1, Sarina Elmariah, MD PhD1*, Paul Yanning Jiang1*, Jennifer Mead, PA1*, Pamela Hodges, PhD, ANP1*, Sarah Elizabeth Valiante1*, Francesca Mernick1*, Karl E Anderson, MD2* and Amy Dickey, MD MSC1*

1Massachusetts General Hospital, Boston, MA
2University of Texas Medical Branch, Galveston

5:45 PM

Tatsuya Morishima, MD, PhD1,2*, Md Fakruddin, PhD2,3*, Takeshi Masuda, PhD4*, Yuxin Wang3*, Vivien A. C. Schoonenberg5*, Falk Butter, PhD5*, Yuichiro Arima, MD, PhD6*, Kazuhito Tomizawa, PhD7*, Fan-Yan Wei, PhD8*, Toshio Suda, MD, PhD9,10 and Hitoshi Takizawa, PhD3

1Laboratory of Stem Cell Stress, International Research Center for Medical Sciences, Kumamoto University, Kumamoto City, Japan
2Laboratory of Hematopoietic Stem Cell Engineering, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan
3Laboratory of Stem Cell Stress, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan
4Department of Pharmaceutical Microbiology, Faculty of Life Sciences Kumamoto University, Kumamoto, Japan
5Quantitative Proteomics, Institute of Molecular Biology, Mainz, Germany
6Laboratory of Developmental Cardiology, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan
7Department of Molecular Physiology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
8Department of Modomics Biology and Medicine, Institite of Development, Aging and Cancer, Tohoku University, Sendai, Japan
9Laboratory of Stem Cell Regulation, International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan
10Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore

*signifies non-member of ASH